Non-invasive Prenatal Testing


Enhance maternal and fetal heath using noninvasive prenatal testing

nipt

Non-invasive prenatal testing (NIPT) is a highly precise and reliable screening test for detecting the most common chromosomal disorders in a baby before birth. It is an advanced technology that can screen for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and sex chromosome abnormalities with unparalleled accuracy. Moreover, it can screen for other chromosomal disorders such as Trisomy 9, 16, and 22, along with deletion syndromes like Cri du Chat (5p-), 1 p36, 2q33.1, Prader-Willi/Angelman (15q11.2), 16p12.2, Jacobsen (11q23), DiGeorge Syndrome II (10p13-14), and a genetic disorder known as VanderWoude (1q32.2). NIPT is a non-invasive, safe, and reliable procedure that poses no risk to the mother or the fetus, and it can be performed as early as 11 weeks into the pregnancy.

Request more information

Testing options

Testing Options
AneuCare Gold (New)
Test Code ANI002
Turn Around Time 10 days
Order Test
AneuCare Silver
Test Code ANI001
Turn Around Time 10 days
Order Test
Karyotyping & FISH for AneuCare Gold
Test Code ANI005
Turn Around Time 15 days
Order Test
Karyotyping + QF-PCR for AneuCare Gold
Test Code ANI006
Turn Around Time 15 days
Order Test
Karyotyping, QF-PCR & MCC for AneuCare Gold
Test Code ANI010
Turn Around Time 15 days
Order Test

This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location. The content on this page is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professionals.